CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
01. Juli 2024 08:00 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel treatm
Entourage Health Extends its Senior Secured Credit Facility Maturity Date
01. Juni 2022 08:03 ET
|
Entourage Health Corp.
TORONTO, June 01, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
EXMceuticals Inc is Pleased to Announce the Signing of the Definitive Business Combination Agreement with Global Cannabinoids and Launch of its up-to $6,000,000 CAD Private Placement
11. Mai 2021 09:00 ET
|
EXMceuticals Inc.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the "Company" or...
Aleafia Health Secures Health Canada Research Licence for Human Sensory Analysis Trials of Cannabis Products
03. Mai 2021 07:05 ET
|
Aleafia Health Inc.
TORONTO, May 03, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, has secured a...
Aleafia Health Introduces Wellness Brand Noon & Night Featuring Omega CBD Soft Gels
13. April 2021 07:30 ET
|
Aleafia Health Inc.
TORONTO, April 13, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its trailblazing new cannabis wellness...
Aleafia Health Reports 2020 Year End Results, Record Quarterly Revenue
25. März 2021 07:15 ET
|
Aleafia Health Inc.
233% increase in Q/Q cannabis net revenue$4.3 million positive adjusted EBITDA in Q4 202042% and 501% increase in Q/Q medical cannabis and adult-use net revenue, respectivelySignificant product...
Aleafia Health Repays $25M Debt with Cash, Provides Update on Sales Growth, New Product Mix
02. Februar 2021 08:00 ET
|
Aleafia Health Inc.
TORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) today announced the full repayment in cash of its 8% unsecured convertible...
Aleafia Health Niagara Greenhouse Deemed EU GACP Compliant, Accelerating International Growth
08. Dezember 2020 07:00 ET
|
Aleafia Health Inc.
TORONTO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that its Niagara Greenhouse facility has been deemed...
EXMceuticals Inc. Announces Shares for Debt Settlement
21. August 2020 21:16 ET
|
EXMceuticals Inc.
VANCOUVER, British Columbia, Aug. 21, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company”) announces that it has settled $1,378,241 of debt with creditors by issuing...
EXMceuticals Inc. Announces Closing of Oversubscribed Private Placement and Strategic Debt to Equity Conversion Strengthening the Corporation’s Balance Sheet
22. Juli 2020 15:18 ET
|
EXMceuticals Inc.
Not for distribution in the U.S. or to U.S. Newswire Services VANCOUVER, British Columbia, July 22, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM") is...